Endoscopic Skull Base Surgery for Sinonasal Malignancy - 05/10/11
, Mark Winder, MD b, Priscilla Parmar, MD a, Valerie Lund, MD cRésumé |
Management of malignant neoplasms of the sinonasal tract and skull base is hampered by the relative low incidence and pathologic diversity of patient presentations. Many studies have reported successful outcomes in the endoscopic management of malignancy since 1996, and these are summarized in this article. Nonsurgical adjuvant therapies are important for locoregional control because surgery occurs in a restricted anatomic space with close margins to critical structures, and distant disease is an ongoing concern in these disorders. There remains a need for collaborative consistent multicenter reporting, and international registries have been established to assist in such efforts.
Le texte complet de cet article est disponible en PDF.Keywords : Esthesioneuroblastoma, Olfactory neuroblastoma, Adenocarcinoma, SCC, Adenocystic, Mucosal melanoma, Sinonasal, Skull base
Plan
| Conflict of interest statement: No external funding was received. Prof. Harvey has served on an advisory board for Schering Plough and serves on the speaker’s bureau for Glaxo Smith Klein. Prof. Lund has served on advisory boards for Bayer, Glaxo Smith Klein, Medtronic, Merck, and Schering Plough. Dr Parmar and Dr Winder have no financial interests to declare. |
Vol 44 - N° 5
P. 1081-1140 - octobre 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
